SCHEMBL7811341

SCHEMBL7811341

CC(C)(Oc1ccc(C2CCN(C(=O)c3ccc(F)cc3)CC2)cc1)C(=O)O

nearest known ligand 0.64

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP10 Q53GL7 3/20 0.64
HSD11B1 P28845 8/20 0.56
NPC1 O15118 1/20 0.55
RAB9A P51151 1/20 0.55
ATM Q13315 1/20 0.55
PARP14 Q460N5 1/20 0.53
ALDH1A1 P00352 3/20 0.52
LMNA P02545 3/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
KDM4E B2RXH2 2/20 0.49
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49
L3MBTL1 Q9Y468 1/20 0.45
GAA P10253 1/20 0.45
CYP2C9 P11712 1/20 0.45
TSHR P16473 1/20 0.45
BLM P54132 1/20 0.45
PPARA Q07869 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7810206 0.90 HSD11B1 (0.54) PARP10HSD11B1PARP14ALDH1A1LMNA
SCHEMBL7804429 0.90 HSD11B1 (0.66) PARP10HSD11B1ALDH1A1LMNASMN1; SMN2
SCHEMBL7810069 0.90 HSD11B1 (0.59) PARP10HSD11B1NPC1RAB9AATM
SCHEMBL7810110 0.89 HSD11B1 (0.51) PARP10HSD11B1MEN1KMT2AGAA
SCHEMBL7813621 0.89 HSD11B1 (0.53) PARP10HSD11B1PARP14ALDH1A1LMNA
SCHEMBL7814102 0.89 HSD11B1 (0.53) PARP10HSD11B1PARP14ALDH1A1LMNA
SCHEMBL7817468 0.89 PPARA (0.57) PARP10HSD11B1ALDH1A1LMNASMN1; SMN2
SCHEMBL7814130 0.87 LMNA (0.54) PARP10HSD11B1ALDH1A1LMNAKDM4E
SCHEMBL7814100 0.87 BCL9 (0.56) PARP10HSD11B1NPC1RAB9AATM
SCHEMBL7804251 0.85 CPS1 (0.47) PARP10PARP14ALDH1A1LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0607536-B1 Arylamide derivatives SS PHARMACEUTICAL CO (JP) 2001-01-24 EP disclosed
US-5532371-A SIDE EFFECT REDUCTION SS PHARMACEUTICAL CO., LTD. (JP) 1996-07-02 US disclosed
US-5411972-A Arylamide derivatives for treating hyperlipemia SS PHARMACEUTICAL CO., LTD. (JP) 1995-05-02 US disclosed
EP-0607536-A1 Arylamide derivatives SS PHARMACEUTICAL CO., LTD. (JP) 1994-07-27 EP disclosed